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Fig. 1. Head and neck lymphadenopathies with inﬂammatory local cutaneous
aspect.. Case report
A 30 year-old woman presented with cervicofacial masses of
0 days’ evolution, progressively increasing in volume (Fig. 1). She
ad no particular history, and worked as a cook. She had 2 dogs,
 cats and 4 rabbits. The cats and rabbits were not vaccinated.
hirteen days earlier, she had cut up a rabbit for cooking. She
hen developed right conjunctivitis with onset of right pre-tragal
nd submandibular lymphadenopathies. One week earlier, she had
ounded herself in the right eye with a tree branch. The conjunc-
ivitis resolved within a week under local treatment with eye-drops
nd ointment, but the lymphadenopathies continued to grow in
olume. She had no recent history of tick bite or being scratched by
 cat. On admission, the patient was free of fever. Clinical examina-
ion found right pre-tragal and submandibular lymphadenopathies,
ith no other particularity. Biological analysis found hyperleukocy-
osis at 15,750 .L−1, ﬁbrinogen at 5.4 g.L−1 and C-reactive protein
t 69.5 mg.L−1. Head and neck contrast-enhanced CT was  per-
ormed (Figs. 2A and 2B).
. QuestionsQuestion 1: how do you interpret these images?
Question 1: what is your diagnostic hypothesis and how can it
e conﬁrmed?
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Fig. 2. A and B. Contrast-enhanced cervic
What is your diagnosis?logy, Head and Neck diseases 131 (2014) 207–209
al CT: A, axial slice; B, coronal slice.
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.1. Reply 1: how do you interpret these images?
Cervical CT with iodized contrast enhancement in axial (2A)
nd coronal slices (2B) shows multiple bilateral lesions predom-
nating on the right, with hypodense centers and peripheral
nhancement, involving the subcutaneous and submucosal regions
parapharyngeal space), suggestive of multiple necrotic cervical
ymphadenopathies. There is also surrounding inﬂammatory tissue
nﬁltration.
.2. Reply 2: what is your diagnostic hypothesis and how can it
e conﬁrmed?
The clinical, biological and CT presentation suggests infectious
ymphadenopathy (adenophlegmon) for the following reasons:
apid evolution toward central necrosis of the cervical lym-
hadenopathies (<10 days), inﬂammatory cutaneous aspect over
he subcutaneous lymphadenopathies (Fig. 1), hyperleukocytosis
ssociated with increased ﬁbrinogen and CRP levels, and multiple
ilateral necrotic cervical lymphadenopathies over different lym-
hatic drainage territories. In this particular case, tularemia is the
ain diagnosis suggested by direct contact with a rabbit, which
s the principal reservoir of Francisella tularensis.  The entry point
t the conjunctiva and the persistence of the lymphadenopathies
uggest an oculo-glandular form.
To conﬁrm this diagnosis, serology should be performed, but
ay  turn out negative as it becomes positive only toward the end
f the second week, peaking around week 4 to 5. In case of strong
uspicion of tularemia despite negative serology, an adenopathy
us sample should be taken for direct examination and/or culture
ith immunoﬂuorescence or quantitative PCR.
. Comments
Tularemia is an infection, rare in France, implicating a
on-capsulated Gram-negative aerobic coccobacillus: F. tularensis.
hese are extremely contagious bacteria, to the point of being
onsidered potential bio-terrorism agents. The disease was  ﬁrst
dentiﬁed in California in 1911 during a “plague-like” epidemic in
odents [1]. The ﬁrst human case was reported in 1914, presenting
s conjuctival ulcer and cervical lymphadenopathy [2]. Tularemia is
ound in several vertebrate species: rabbit, hare, squirrel, sheep, cat,
eaver, hamster, musk-rat, vole and mouse [3]. The most frequent
ontamination route is cutaneo-mucosal. Transmission is by direct
ontact with infected animals, insect bites, inhalation related to
andling contaminated animals or substances, or ingestion of con-
aminated water or undercooked meat. There have been no reports
f human-to-human transmission, and patients do not need to be
eld in isolation.
Incubation time is generally 3 to 5 days, although this may range
rom 1 to 21 days [3]. Disease may  be asymptomatic or progress
oward sepsis, which may  be fatal if untreated. Six different clinical
orms are possible, depending on the transmission site: ulcero-
landular (ulcerated skin lesion, eventually a scab and lymph node
[
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in the drainage territory), pure glandular without skin lesion, oculo-
glandular (corneal ulcer or nodule), septicemic or pseudo-typhoid,
oropharyngeal, or pulmonary. Symptoms or signs localized to the
head and neck region were reported in 11% to 45% of patients with
tularemia [3]. In the present case, transmission was  probably via the
hands to the right conjunctival wound, resulting in conjunctivitis
and lymphadenopathy of the drainage territory.
The interval between onset and diagnosis ranges between 5
days and 6 months [3]. Fluctuating uni- or bilateral upper cervical
masses indicative of abscess formation are found in 78.9% of cases
[4]. Cagh et al. reported 8 out of 33 cases associated with fever.
Biological disturbance is non-speciﬁc. In head and neck involve-
ment, ultrasound or CT is required to assess tumefaction. Massive
lymphadenopathies with necrotic centers, found in 85.7% of cases
[4], are the main target in ultrasound exploration [3]. CT helps
assessment of deep extension of necrotic lymphadenopathies or
abscesses [3] (Figs. 2A and 2B).
Diagnosis is conﬁrmed by direct examination or culture of blood,
bronchoalveolar lavage ﬂuid, cerebrospinal ﬂuid, scab sample,
throat swab, biopsy samples of lymph nodes or skin ulcer, or spec-
imens of necrotic lymphadenopathy puncture. F. tularensis may  be
detected by direct immunoﬂuorescence or by gene ampliﬁcation
on quantitative PCR with a speciﬁc probe [5], which is the most
sensitive, speciﬁc and rapid technique. Indirect diagnosis relies
on serology with indirect immunoﬂuorescence, seroagglutination,
micro-agglutination, hemagglutination and Elisa test. Serology
becomes positive only near the end of the second week, peaking
around week 4 to 5. There are, unfortunately, cross-reactions with
Brucella spp., Proteus OX19 and Yersinia spp. In the present case, diag-
nosis involved quantitative PCR, as initial serology was negative.
Treatment consists in antibiotherapy with or without surgical
drainage of the abscess. The recommended agent is Gentamicin®
5 mg/kg/day for 10 days. This may  induce renal and/or auditory
impairment and therefore requires surveillance. In less severe
forms, the WHO  has recently recommended oral Ciproﬂoxacin
400–500 mg  twice daily for 10 to 14 days or Doxycycline 100 mg
twice daily for at least 15 days [5]. The present patient took Doxy-
cycline for a total of 21 days, associated to puncture-drainage at
the beginning of the antibiotherapy. Head and neck CT at 1 month
found almost total regression of the initial abnormalities.
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